$347,558
＋4.5%
Chief MED Officer
2024
$348k org
50 hrs/wk
Chief MED Officer at Foundation for the Accreditation of Cellular Therapy
Fiscal year ended December 31, 2024. Published on January 25, 2026.
Total compensation
Phyllis Warkentin, M.D. has been listed as an employee of Foundation for the Accreditation of Cellular Therapy in Form 990 filings since fiscal year 2022. Total compensation for Phyllis Warkentin, M.D. has increased by 8.5% from 2022 to 2024.